Ajax-Loading

Sino Biopharmaceutical Ltd - Other Stockholder Equity

Sino Biopharmaceutical Ltd's Fiscal Year is From January To December - All Figures are in HKD, Billions.

The item "Other-Stockholder-Equity" stands at 21.74 Billion Hong Kong Dollars as of 06/30/2025, the highest value since 03/31/2024.

As of the end of Sino Biopharmaceutical Ltd's second quarter, the item "Other Stockholder Equity" stands at 21.74 Billion HKD. This represents no change compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 3.51 Billion Hong Kong Dollars compared to the value the year prior.
The 1 year change is 3.51 Billion Hong Kong Dollars.
The 3 year change is 2.10 Billion Hong Kong Dollars.
The 5 year change is -0.741 Billion Hong Kong Dollars.
The 10 year change is 19.10 Billion Hong Kong Dollars.

The Serie's long term average value is 7.09 Billion Hong Kong Dollars. It's latest available value, on 06/30/2025, is 14.65 Billion Hong Kong Dollars higher, compared to it's long term average value.
The Serie's change in Hong Kong Dollars from it's minimum value, on 09/30/2020, to it's latest available value, on 06/30/2025, is +45.03 Billion.
The Serie's change in Hong Kong Dollars from it's maximum value, on 12/31/2022, to it's latest available value, on 06/30/2025, is -2.80 Billion.

Other Stockholder Equity for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Other Stockholder Equity905,699,262,464.00
LogoJohnson & Johnson - Other Stockholder Equity486,508,953,600.00
LogoAbbVie Inc - Other Stockholder Equity399,570,305,024.00
LogoRoche Holding AG - Other Stockholder Equity317,433,206,677.55
LogoAstraZeneca PLC - Other Stockholder Equity280,205,508,085.11